Skip to main content

Shed Review 2026

Sarah Chen
Sarah ChenLead Health Editor
Updated March 30, 2026
Illustration for: Shed Review 2026

Shed Review 2026: Men's GLP-1 + TRT Integration, Pricing, and Honest Assessment

Medically reviewed by Telehealth Ally Medical Review Team. Pricing and protocol data last verified April 2026.

Shed is a men's health telehealth platform that offers compounded GLP-1 medications alongside testosterone replacement therapy, ED treatment, and hair loss care — all through one clinical team. At $175/month for compounded semaglutide, it sits in the mid-range of the GLP-1 market. The case for it is narrow and specific: men dealing with weight gain and low testosterone who want both conditions managed by one provider, on video, without juggling separate care teams.

Pricing last verified April 2026. We update pricing data monthly. Contact us if you spot an error.

How much does Shed cost per month?

Shed charges $175/month for compounded semaglutide and $325/month for compounded tirzepatide — both prices are all-inclusive, covering consultation and medication with no separate membership fee. Shed uses straightforward, all-in pricing. There's no separate membership fee or consultation charge billed on top of medication costs.

Medication Monthly Cost What's Included
Compounded semaglutide $175/mo Consultation + medication
Compounded tirzepatide $325/mo Consultation + medication

For context, Ro charges $149/month for compounded semaglutide, and Hims runs $199/month. Shed's $175 sits between them. On tirzepatide, $325/month is consistent with mid-range compounded market pricing — competitors like Henry Meds and Mochi Health land in similar territory.

Shed does not offer brand-name GLP-1 medications (Ozempic, Wegovy, Mounjaro, or Zepbound). If you need insurance coverage or have a clinical reason for the brand product, you'll need to go elsewhere.

Payment is cash-pay only. HSA and FSA cards are accepted.

How does Shed work?

Shed's intake and care process runs as follows:

  1. Online intake form — You complete a medical history questionnaire covering symptoms, health goals, current medications, and relevant history. The intake is designed around the full men's health picture — not just weight.
  2. Video consultation — A licensed physician reviews your case over video, discusses your treatment options, and determines whether compounded GLP-1 therapy (and potentially TRT) is appropriate. This is a genuine differentiator at this price point — Hims and Ro both use async-only models for weight loss.
  3. Lab work — Labs are recommended but not included in the monthly fee. Shed can order panels through partner labs if needed; this is an additional out-of-pocket cost.
  4. Prescription and shipping — Medication ships from partner compounding pharmacies, typically arriving within 3–5 business days.
  5. Ongoing care — Follow-up appointments are available through the platform for dose adjustments and monitoring.

The video consult model isn't just a checkbox. For men where TRT and GLP-1 therapy may interact — particularly around body composition, testosterone levels, and metabolic response — having that conversation on video rather than through a questionnaire allows more nuance.

Who is Shed best for?

Shed makes the most sense for men dealing with two problems at once: weight gain and low testosterone. These conditions often overlap and benefit from a single provider managing both.

Hypogonadism contributes to fat accumulation and insulin resistance. Excess visceral fat suppresses testosterone production. Managing weight and testosterone through separate providers means neither doctor has the full picture. GLP-1 medications and TRT both affect body composition and metabolic health, and their interactions can be significant — a prescribing physician who only sees one side of that equation is working with incomplete information.

Shed's clinical team is structured around this overlap. If you're already considering TRT or are on it, and you want to add a GLP-1 medication, consolidating that care under one team is worth something — even if the monthly price isn't the absolute lowest available.

Shed is not the right choice if:

  • You only want a GLP-1 prescription and aren't dealing with concurrent testosterone or hormonal issues. Ro or Henry Meds will cost less.
  • You want brand-name GLP-1 medications. Shed doesn't offer them.
  • You're not male — Shed's platform is built around men's health and is positioned accordingly.
  • You live in one of the 8 states Shed doesn't yet serve. Check their website for current availability before starting the intake process.

What are the pros and cons of Shed?

Pros Cons
Video consultations included — not async-only Men-only platform
GLP-1 and TRT can be managed under one provider Available in 42 states only (not all 50)
Straightforward single-price billing, no membership fee No brand-name GLP-1 medications
Physicians understand hormonal interactions affecting weight No dietitian access or dedicated coaching
HSA/FSA eligible Lab work not included — additional cost
Newer to GLP-1 prescribing (expanded from TRT/ED in 2024) — less track record than established players

How does Shed compare to Hims and Ro?

At $175/month for compounded semaglutide, Shed costs more than Ro ($149) but less than Hims ($199) — a difference of $26–$300 per year depending on which competitor you're comparing. For men who just want the cheapest way to get semaglutide online, Ro at $149/month is the simpler choice.

The more relevant gap is clinical model. Hims and Ro use async workflows for weight loss: questionnaire in, prescription out, follow-up via messaging. Shed offers video consultations, which allows a more thorough conversation. For men managing GLP-1 therapy alongside TRT, that difference in access matters more than the price delta.

Neither Hims nor Ro offers TRT-GLP-1 coordination through a shared clinical team. Hims offers TRT separately through a different program. If you want both managed together, Shed is currently one of the few structured options in the telehealth market for this.

What about Shed's compounded GLP-1 medications?

Shed prescribes compounded semaglutide and tirzepatide — not the FDA-approved brand-name drugs. Compounded medications use the same active pharmaceutical ingredient but are prepared by compounding pharmacies (not by the original drug manufacturers) and are not individually evaluated or approved by the FDA as finished drug products.

The regulatory environment around compounded GLP-1s is active. The FDA has been enforcing restrictions on compounding as brand-name supply normalizes. This affects all compounded GLP-1 providers, not Shed specifically — but it means the availability of compounded medications could change. As of April 2026, compounded semaglutide supply is declining under FDA enforcement pressure. If continuity of supply matters to you, discuss it directly with the prescribing team.

Shed's partner compounding pharmacies are reported to follow quality standards consistent with PCAB accreditation, though you should verify pharmacy details during your consultation.

Is Shed worth it?

Shed fills a genuine gap. The ability to prescribe GLP-1 therapy and TRT through a single care team — with video-based consultations and physicians who understand how these treatments interact — addresses a real clinical need that most telehealth platforms ignore. Whether Shed is worth it depends on whether you're in that specific patient profile: a man managing both weight and testosterone.

At $175/month for compounded semaglutide, Shed is priced fairly for what it offers. The video consult alone is worth something compared to async-only competitors in the same price range. If you add the TRT coordination, the value case gets clearer for the right patient.

But Shed's strengths are narrow. The men-only focus is a feature for some patients and a dealbreaker for others. The 42-state footprint is more limited than Hims (50 states) or Mochi (49 states). There's no dietitian, no coaching, no brand-name option. Shed is newer to weight management specifically — having expanded from TRT and ED in 2024 — and the operational maturity of its GLP-1 program hasn't been tested at scale the way established competitors have.

Shed is a reasonable choice for a specific patient: a man dealing with weight gain and low testosterone who wants face-to-face care and one clinical team managing both. If that's you, it's worth a consultation. If you want the cheapest compounded GLP-1 without the complexity, Ro or Henry Meds at $149/month do the job for less.

Frequently Asked Questions

Is Shed legit? Yes. Shed is a licensed men's health telehealth platform operating with licensed physicians. It is cash-pay only, with partner compounding pharmacies reported to follow quality standards consistent with PCAB accreditation. It expanded into GLP-1 prescribing in 2024 from an established TRT and ED base.

How much does Shed cost per month? $175/month for compounded semaglutide (consultation + medication, all-in). $325/month for compounded tirzepatide. No separate membership fee. Labs are an additional cost if needed.

Does Shed take insurance? No. Shed is cash-pay only. HSA and FSA cards are accepted. Shed does not offer brand-name GLP-1 medications that could be covered by insurance.

Is Shed only for men? Yes. Shed's platform is built around men's health — GLP-1, TRT, ED, and hair loss. It does not serve women.

How does Shed compare to Ro for GLP-1? Ro is $149/month for compounded semaglutide with async-only care. Shed is $175/month with video consultations included. Shed adds TRT coordination in one platform; Ro does not offer this. For men managing both conditions, Shed's integrated model justifies the price difference. For men who only want GLP-1, Ro is cheaper.

What states does Shed serve? Shed operates in 42 states as of April 2026. Check Shed's website for current state availability before starting the intake process.


Data Sources & Methodology

Pricing and protocol data sourced from Shed Rx's public website and verified via checkout flow, April 2026. Patient experience data drawn from public reviews (Google, Trustpilot, Reddit) and independent patient outreach. Telehealth Ally has no commercial relationship with this provider. Rankings and ratings are editorial-only.

Sarah Chen

Sarah Chen

Lead Health Editor

Sarah covers telehealth and digital health access. She has spent 8 years in health journalism, previously writing for health policy publications. She leads editorial at Telehealth Ally.

Get weekly GLP-1 pricing updates

We track prices so you don't have to.

No spam. Unsubscribe anytime.

50+ providers trackedUpdated weekly100% independent